Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TK2 | O00142 | 7/20 | 0.36 |
| ▸ | RNASE1 | P07998 | 1/20 | 0.35 |
| ▸ | TK1 | P04183 | 4/20 | 0.34 |
| ▸ | TYMP | P19971 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4952762 | 0.85 | TK2 (0.39) | TK2RNASE1TK1TYMP | |
| SCHEMBL4470358 | 0.83 | TK2 (0.34) | TK2RNASE1TK1TYMP | |
| SCHEMBL5668670 | 0.83 | RNASE1 (0.37) | TK2RNASE1TK1TYMP | |
| SCHEMBL6223881 | 0.82 | TK2 (0.33) | TK2RNASE1TK1TYMP | |
| SCHEMBL7639912 | 0.81 | TK1 (0.34) | TK2RNASE1TK1 | |
| SCHEMBL3300461 | 0.79 | TK2 (0.38) | TK2RNASE1TK1TYMP | |
| SCHEMBL3516066 | 0.77 | TK2 (0.32) | TK2TK1 | |
| SCHEMBL7211344 | 0.77 | PNP (0.38) | TK1 | |
| SCHEMBL7156110 | 0.77 | TK1 (0.34) | TK1 | |
| SCHEMBL3696551 | 0.77 | RNASE1 (0.36) | TK2RNASE1TK1TYMP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 211 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1631235-A4 | COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | ISIS PHARMACEUTICALS INC (US) | 2008-05-21 | — | — | EP | disclosed |
| EP-1613728-A4 | MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION | ISIS PHARMACEUTICALS INC (US) | 2007-07-25 | — | — | EP | disclosed |
| EP-1718762-A1 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF STAT3 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2006-11-08 | — | — | EP | disclosed |
| EP-1648910-A2 | ANTISENSE MODULATION OF STEAROYL-COA DESATURASE EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2006-04-26 | — | — | EP | disclosed |
| EP-1633302-A2 | MODULATION OF APOLIPOPROTEIN (A) EXPRESSION | Isis Pharmaceuticals, Inc. (US) | 2006-03-15 | — | — | EP | disclosed |
| EP-1631235-A2 | COMPOSITIONS AND METHODS FOR THE MODULATION OF THE EXPRESSION OF B7 PROTEIN | Isis Pharmaceuticals, Inc. (US) | 2006-03-08 | — | — | EP | disclosed |
| EP-1629084-A2 | MODULATION OF C-REACTIVE PROTEIN EXPRESSION | Isis Pharmaceuticals, Inc. (US) | 2006-03-01 | — | — | EP | disclosed |
| EP-1613728-A2 | MODULATION OF DIACYLGLYCEROL ACYLTRANSFERASE 1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2006-01-11 | — | — | EP | disclosed |
| WO-2005083124-A1 | ANTISENSE OLIGONUCLEOTIDE MODULATION OF STAT3 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-09 | — | — | WO | disclosed |
| EP-1569695-A2 | ANTISENSE MODULATION OF APOLIPOPROTEIN B EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2000036150-A1 | ANTISENSE MODULATION OF ELK-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000033889-A1 | ANTISENSE MODULATION OF G-ALPHA-13 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000034302-A1 | ANTISENSE MODULATION OF EGR-1 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000032818-A1 | ANTISENSE MODULATION OF CELLULAR INHIBITOR OF APOPTOSIS-2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000032817-A1 | ANTISENSE MODULATION OF G-ALPHA-16 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-08 | — | — | WO | disclosed |
| WO-2000031296-A1 | ANTISENSE MODULATION OF INTERLEUKIN-15 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000030686-A1 | ANTISENSE MODULATION OF INHIBITOR-KAPPA B KINASE-ALPHA EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000031103-A1 | ANTISENSE MODULATION OF MEK2 EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000031105-A1 | ANTISENSE MODULATION OF INHIBITOR-KAPPA B KINASE-BETA EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-02 | — | — | WO | disclosed |
| WO-2000031111-A1 | ANTISENSE MODULATION OF NF-KAPPA-B P65 SUBUNIT EXPRESSION | ISIS PHARMACEUTICALS, INC. (US) | 2000-06-02 | — | — | WO | disclosed |